Harsh economics dampen appetite for healthcare IT
The weakened U.S. economy is slowing the pace of growth in healthcare IT, according to a survey conducted by HIMSS. Only a little more than half (55%) of the 304 respondents participating the 20th annual HIMSS Leadership Survey said their IT budgets would increase, compared to 78% last year. This year about 42% said their staffing levels would increase, down from 68% last year.
The weakened U.S. economy is slowing the pace of growth in healthcare IT, according to a survey conducted by HIMSS. Only a little more than half (55%) of the 304 respondents participating in the 20th annual HIMSS Leadership Survey said their IT budgets would increase, compared to 78% last year. This year about 42% said their staffing levels would increase, down from 68% last year.
Survey respondents noted, however, that their organizations remain committed to healthcare IT. Implementing EMR systems is at the top of “to-do” lists held by IT professionals. About 31% said the primary focus would be ensuring their organization has a full EMR. Another 17% indicated that their the primary focus would be to install a CPOE (computerized provider order entry).
HIMSS noted that many respondents completed the survey prior to the Feb. 17 signing of the American Reinvestment and Recovery Act (ARRA), which is designed to encourage the adoption of healthcare IT by providing financial incentives to use health information exchanges.
As in past years, security issues remain a big concern as 84% of respondents said their organization actively assesses security risks. One in four said they have had a security breach in the past year. To address the risks, 49% said they plan to purchase single sign-on technology in the next year. Currently, 31% said they have single sign-on technology. A third or more respondents said they plan to purchase other security measures, such as e-mail encryption, biometric technologies, intrusion prevention/detection service, and data encryption. Currently, 62 % use e-mail encryption; 18% use biometric technologies; 75% use intrusion prevention/detection service; and 56% use data encryption.
SNMMI: Can 18F-Fluciclovine PET/CT Bolster Detection of PCa Recurrence in the Prostate Bed?
June 24th 2025In an ongoing prospective study of patients with biochemical recurrence of PCa and an initial negative PSMA PET/CT, preliminary findings revealed positive 18F-fluciclovine PET/CT scans in over 54 percent of the cohort, according to a recent poster presentation at the SNMMI conference.
Could an Emerging PET Tracer be a Game Changer for Detecting Hepatocellular Carcinoma?
June 23rd 2025In addition to over 90 percent sensitivity in detecting hepatocellular carcinoma (HCC), the glypican-3 (GPC3) targeted PET tracer 68Ga-aGPC3-scFv appeared to be advantageous in identifying HCC tumors smaller than one centimeter, according to pilot study findings presented at the SNMMI conference.
SNMMI: What a New Meta-Analysis Reveals About Radiotracers for PET/CT Detection of PCa
June 22nd 2025While (68Ga)Ga-PSMA-11 offers a pooled sensitivity rate of 92 percent for prostate cancer, (18F)-based radiotracers may offer enhanced lesion detection as well as improved imaging flexibility, according to a meta-analysis presented at the Society for Nuclear Medicine and Molecular Imaging (SNMMI) conference.
